PharmacoEconomics

Trastuzumab in Early-Stage Breast Cancer: The Question of Treatment Timing
pp. 807-809(3)
Author: Simoens, Steven

Funding a Clinical Trial: The Perspective of a Medicines Funder
pp. 811-814(4)
Authors: Alsop, Peter; Metcalfe, Scott; Evans, Jackie

Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?
pp. 815-830(16)
Authors: Rappange, David R.; van Baal, Pieter H.M.; van Exel, N. Job A.; Feenstra, Talitha L.; Rutten, Frans F.H.; Brouwer, Werner B.F.

Quality-of-Life Assessment in Rheumatoid Arthritis
pp. 831-846(16)
Author: Russell, Anthony S.

Multiple Sclerosis in the UK: Service Use, Costs, Quality of Life and Disability
pp. 847-860(14)
Authors: McCrone, Paul; Heslin, Margaret; Knapp, Martin; Bull, Paul; Thompson, Alan

Costs and Effects of Secondary Prevention with Perindopril in Stable Coronary Heart Disease in Poland: An Analysis of the EUROPA Study Including 1251 Polish Patients
pp. 861-877(17)
Authors: Redekop, W. Ken; Orlewska, Ewa; Maciejewski, Pawel; Rutten, Frans F.H.; Niessen, Louis W.

Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure: An Individual Patient-Based Simulation Model
pp. 879-889(11)
Authors: Yao, Guiqing; Freemantle, Nick; Flather, Marcus; Tharmanathan, Puvan; Coats, Andrew; Poole-Wilson, Philip A.

Assessing the Value of a Future Study
pp. 891-892(2)
Author: Gandjour, Afschin

The Authors' Reply
pp. 892-894(3)
Authors: Shavit, Oren; Leshno, Moshe; Goldberger, Assaf; Shmueli, Amir; Hoffman, Amnon